It has been revealed that IL-6 trans-signaling via sIL-6R derived by myeloid cells attenuates CD4+ T helper type 1 (Th1) cell differentiation in tumor-bearing mice, leading to defective anti-tumor responses69. Here, CD4 is linked to neoplasm.